New publication in the Front. Bioeng. Biotechnol.

In this study, we found that treatment of FOXO4-DRI, a senolytic peptide, removed senescent cells in extensively expanded chondrocytes but did not significantly affect the viability of normal chondrocytes. This method may also enhance the reparative capacity of autologous chondrocyte implantation via selectively killing senescent cells.